Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Mayur Ian Somaiya files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael H. Davidson - $25.33M of NAMS open-market activity in the last 12 months
- Louise Frederika Kooij - $21.08M of NAMS open-market activity in the last 12 months
- Johannes Jacob Pieter Kastelein - $14.26M of NAMS open-market activity in the last 12 months
- Louis G. Lange - $2.19M of NAMS open-market activity in the last 12 months
- James N. Topper - $47K of NAMS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mayur Ian Somaiya?
Mayur Ian Somaiya is a corporate insider, tracked as Chief Financial Officer of NewAmsterdam Pharma Co N.V. (NAMS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mayur Ian Somaiya last file a Form 4?
The most recent primary Form 4 on record is dated 22 January 2026, one of 2 filings going back to 2026.
Has Mayur Ian Somaiya been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($3.43M) across all tracked filings.
Where can I see all of Mayur Ian Somaiya's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mayur Ian Somaiya and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
